Banco Santander, S.A. Ocular Therapeutix, Inc Transaction History

Banco Santander, S.A.

$8.47 Billion
Q3 2024

A detailed history of Banco Santander, S.A. transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Banco Santander, S.A. holds 172,231 shares of OCUL stock, worth $1.63 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

172,231

Previous 377,368 54.36%

Holding current value

$1.63 Million

Previous $2.58 Million 41.96%

% of portfolio

0.02%

Previous 0.03%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$6.45 - $9.23 $1.32 Million - $1.89 Million	-205,137 Reduced 54.36%	172,231 $1.5 Million
Q2 2024 Jul 29, 2024	BUY	$4.2 - $8.69 $710,522 - $1.47 Million	169,172 Added 81.26%	377,368 $2.58 Million
Q1 2024 May 10, 2024	SELL	$3.85 - $10.93 $1.28 Million - $3.63 Million	-332,280 Reduced 61.48%	208,196 $1.89 Million
Q4 2023 Feb 09, 2024	BUY	$2.08 - $4.52 $297,508 - $646,509	143,033 Added 35.99%	540,476 $2.41 Million
Q2 2023 Aug 14, 2023	BUY	$4.6 - $7.64 $595,948 - $989,792	129,554 Added 48.36%	397,443 $2.05 Million
Q1 2023 May 10, 2023	SELL	$2.79 - $6.27 $168,585 - $378,864	-60,425 Reduced 18.4%	267,889 $1.41 Million
Q4 2022 Feb 13, 2023	SELL	$2.61 - $4.41 $63,937 - $108,031	-24,497 Reduced 6.94%	328,314 $922,000
Q3 2022 Nov 08, 2022	SELL	$4.09 - $6.5 $830,568 - $1.32 Million	-203,073 Reduced 36.53%	352,811 $1.46 Million
Q2 2022 Jul 28, 2022	BUY	$3.01 - $5.22 $1.67 Million - $2.9 Million	555,884 New	555,884 $2.24 Million

Others Institutions Holding OCUL

# of Institutions

172

Shares Held

138M

Call Options Held

150K

Put Options Held

225K

View Full List

About OCULAR THERAPEUTIX, INC

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $727M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

More about OCUL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Banco Santander, S.A., based on Form 13F filings with the SEC.

News

Stay updated on Banco Santander, S.A. with notifications on news.

Account

Banco Santander, S.A. Ocular Therapeutix, Inc Transaction History